Crescent Biopharma
CBIO
13.49
-0.08
-0.59%
Crescent Biopharma
US · CBIO
#3749 by market cap
13.49
-0.08
-0.59%
Live - 5344 symbols - heartbeat 56s ago
· 2026-10-08 02:25
After-hours
13.49
0.00%
Overnight
13.16
-2.45%
- Market cap
- 501.07M
- P/E (TTM)i
- -96.36
- P/Bi
- 3.15
- EPSi
- -12.81
- Div yieldi
- 0.00%
- 52W posi
- 26%
Reader sentiment
Are you bullish or bearish on CBIO?
Anonymous reader poll. Unscientific, not investment advice.
About Crescent Biopharma
Crescent Biopharma, Inc. operates as a biopharmaceutical company that develops and designs small molecule therapeutics to treat cancers. The company was founded on September 19, 2024 and is headquartered in Waltham, MA.
- Founded
- 2024
- CEO
- Mr. Joshua T. Brumm
- Employees
- 44
- Headquarters
- Waltham, Massachusetts, United States of America
- Fiscal year end
- 12-31
- Website
- crescentbiopharma.com
Company profile
- Exchange
- US
- Symbol
- CBIO
- Market-cap rank
- #3749
- Market cap
- 501.07M
- Float cap
- 249.38M
- Shares out
- 37.14M
- Float shares
- 18.49M
Sectors & themes
Quote time 2026-10-08 02:25:01 · For reference only, not investment advice and not tailored to your situation.